Proteasome inhibition as a therapeutic strategy for hematologic malignancies.


The ubiquitin-proteasome pathway is a principal intracellular mechanism for controlled protein degradation and has recently emerged as an attractive target for anticancer therapies since several cell cycle regulators and modulators of apoptosis are degraded through this pathway. The current state of the field of proteasome inhibitors and their prototypic… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.